stool collection

PreclinicalBiologic

AAssistance Publique - Hôpitaux de Paris

stool collection is one of 9 biologic programs targeting Humans. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

HumansCompleted

HumansPreclinical

Completed

Competition

Competitive Landscape

11 competitors in Humans

#DrugCompanyPhaseTrials

Lexapro

AbbVie

Approved

1 2

Reboxetine

UUniversity of Zurich

Preclinical

1 3

Remitch

SShandong New Time Pharmaceutical Co., LTD

Preclinical

1 4

Astaxanthin

SSheba Medical Center

Preclinical

1 5

Salmonella Typhi

UUniversity of Oxford

Preclinical

1 6

Nalfurafine Hydrochloride

SShandong New Time Pharmaceutical Co., LTD

Preclinical

1 7

GLP-2

GGlostrup University Hospital, Copenhagen

Preclinical

1 8

stool collection

AAssistance Publique - Hôpitaux de Paris

Preclinical

1 9

PBR111

UUniversity of North Carolina, Chapel Hill

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q1 2029

Recruiting

Rejection

NCT07134491

Clinical

Trials by Indication[1]

Humans1 trial

Viral and Microbial Circulation Between Humans, Domesticated and Wild Animals Along an Ecotone, Democratic Republic of Congo

Completed·IInstitut Pasteur·N/A·NCT04012164·60 enrolled

Rejection1 trial

Peripheral and Intrarenal B Cell Study in Antibody Mediated Transplant Rejection : Phenotypic and Transcriptional Study, Study of Reactivity

Recruiting·AAssistance Publique - Hôpitaux de Paris··NCT07134491·45 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for stool collection. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — stool collection compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for stool collection. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Assistance Publique - Hôpitaux de Paris company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Preclinical[1]
Company: AAssistance Publique - Hôpitaux de Paris

stool collection

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q1 2029

Trials by Indication[1]

Humans1 trial

Rejection1 trial

References

Drug Info

Quick Facts

Related News